SCHEMBL6604679

SCHEMBL6604679

NN1C=CC=CC1[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28950102 0.74
SCHEMBL8524496 0.66 ALDH1A1 (0.32)
SCHEMBL28950107 0.65 ALDH1A1 (0.39)
SCHEMBL13720346 0.62
SCHEMBL2043921 0.62
SCHEMBL23198636 0.59
SCHEMBL6850009 0.56
SCHEMBL13136762 0.56
SCHEMBL31439039 0.55
SCHEMBL2085606 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023291-B1 DIPYRIDOIMIDAZOLDERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS ORTHO MCNEIL PHARM INC (US) 2004-05-26 EP disclosed
EP-1023291-A1 DIPYRIDOIMIDAZOLDERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS Ortho-McNeil Pharmaceutical, Inc. (US) 2000-08-02 EP disclosed
US-5968946-A FUSED PYRROLO-IMIDAZOPYRIDINE DERIVATIVES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-10-19 US disclosed
WO-1999018105-A1 DIPYRIDOIMIDAZOLDERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-04-15 WO disclosed